AJMC Staff

Coverage of our peer-reviewed research in the healthcare and mainstream press.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

An update on the latest developments in the world of oncology care: product approvals, clinical developments, health policy changes, and more.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

The number of individuals from Indiana in the Trump administration has increased: Jerome M. Adams, MD, the former Indiana health commissioner was confirmed by the Senate as the new surgeon general. Adams replaces Vivek Murthy, MD, who was pushed out by the Trump administration in April.

Venetoclax (Venclexta), in combination with low dose cytarabine, has been granted a breakthrough therapy designation for use in elderly, treatment-naive patients with acute myeloid leukemia (AML) who cannot handle intensive chemotherapy.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

According to outcome results presented at a plenary session at the 2017 American Society of Clinical Oncology Annual Meeting, patients receiving routine outpatient chemotherapy for metastatic solid tumors who self-reported 12 common symptoms via tablet computers experienced an overall survival benefit over those who received usual care.

A poster session at the 2017 American Society of Clinical Oncology Annual Meeting presented the trial details of IRONCLAD, a randomized phase 3 study of ibrutinib versus no consolidation following autologous hematopoietic stem cell transplantation for activated-B-cell subtype relapsed diffuse large B-cell lymphoma.